Literature DB >> 3329816

Pathogenesis and significance of urogenital mycoplasmal infections.

G H Cassell1, J K Davis, K B Waites, P T Rudd, D Talkington, D Crouse, S A Horowitz.   

Abstract

U. urealyticum and M. hominis can no longer be considered as harmless commensals of the lower genitourinary tract. Both can produce disease in humans. Diagnosis and management of infections due to these organisms must be based upon isolation of the organisms from the affected site and preferably the number of organisms present. Due to the frequent resistance of both organisms to tetracycline, treatment must be based upon appropriate antibiotic sensitivities. For a more detailed description of the basic biology of these organisms and isolation and identification and treatment, the reader is referred to several recent reviews.

Entities:  

Mesh:

Year:  1987        PMID: 3329816     DOI: 10.1007/978-1-4684-8932-3_10

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  7 in total

1.  Hydrolysis of urea by Ureaplasma urealyticum generates a transmembrane potential with resultant ATP synthesis.

Authors:  D G Smith; W C Russell; W J Ingledew; D Thirkell
Journal:  J Bacteriol       Date:  1993-06       Impact factor: 3.490

2.  In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391.

Authors:  K B Waites; L B Duffy; T Schmid; D Crabb; M S Pate; G H Cassell
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

3.  Ureaplasma diversum infection in vitro alters prostaglandin E2 and prostaglandin F2a production by bovine endometrial cells without affecting cell viability.

Authors:  J J Kim; P A Quinn; M A Fortier
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

4.  Ureaplasma urealyticum and Mycoplasma hominis detected by the polymerase chain reaction in the cervices of women undergoing in vitro fertilization: prevalence and consequences.

Authors:  S S Witkin; I Kligman; J A Grifo; Z Rosenwaks
Journal:  J Assist Reprod Genet       Date:  1995-10       Impact factor: 3.412

5.  In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones.

Authors:  K B Waites; G H Cassell; K C Canupp; P B Fernandes
Journal:  Antimicrob Agents Chemother       Date:  1988-10       Impact factor: 5.191

6.  Genital mycoplasmas in placental infections.

Authors:  A Stein; L Boubli; B Blanc; D Raoult
Journal:  Infect Dis Obstet Gynecol       Date:  1994

7.  In vitro susceptibility of Ureaplasma urealyticum and Mycoplasma hominis isolates in Argentina.

Authors:  J Smayevsky; S Relloso; M Pundik; A Lanza; G Weltman; C Bantar; H Bianchini
Journal:  Infect Dis Obstet Gynecol       Date:  1995
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.